AU1197001A - B cell clonal toxins and methods for using the same - Google Patents
B cell clonal toxins and methods for using the sameInfo
- Publication number
- AU1197001A AU1197001A AU11970/01A AU1197001A AU1197001A AU 1197001 A AU1197001 A AU 1197001A AU 11970/01 A AU11970/01 A AU 11970/01A AU 1197001 A AU1197001 A AU 1197001A AU 1197001 A AU1197001 A AU 1197001A
- Authority
- AU
- Australia
- Prior art keywords
- toxins
- methods
- same
- cell clonal
- clonal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16246499P | 1999-10-29 | 1999-10-29 | |
US60162464 | 1999-10-29 | ||
PCT/US2000/028157 WO2001032853A1 (en) | 1999-10-29 | 2000-10-12 | B cell clonal toxins and methods for using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1197001A true AU1197001A (en) | 2001-05-14 |
Family
ID=22585734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11970/01A Abandoned AU1197001A (en) | 1999-10-29 | 2000-10-12 | B cell clonal toxins and methods for using the same |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1197001A (en) |
WO (1) | WO2001032853A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10041560A1 (en) * | 2000-08-24 | 2002-03-07 | Max Delbrueck Centrum | New peptide from the alpha1 adrenergic receptor, useful for diagnosis and treatment of psoriasis, and also for raising specific antibodies |
ATE466871T1 (en) * | 2001-07-13 | 2010-05-15 | Cms Peptides Patent Holding Co | BIOLOGICALLY ACTIVE PEPTIDES |
EP1419173B1 (en) * | 2001-08-10 | 2008-11-26 | Novartis AG | Peptides that bind to atherosclerotic lesions |
EP1684785A4 (en) * | 2003-11-14 | 2009-08-12 | Jay W Chaplin | B cell-targeted toxins for humoral immune response reduction |
WO2012107932A1 (en) * | 2011-02-11 | 2012-08-16 | Transgene Biotek Ltd. | B cell clonal immunotoxin and use thereof |
CN109467599B (en) * | 2017-09-08 | 2021-06-04 | 武汉华纪元生物技术开发有限公司 | Short peptide ATR001, monoclonal antibody prepared from short peptide and having function of preferentially regulating AT1R, and application of monoclonal antibody |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5831142A (en) * | 1994-01-07 | 1998-11-03 | Dana Farber Cancer Institute, Inc. | Regulatory elements controlling tissue-specific gene expression |
-
2000
- 2000-10-12 WO PCT/US2000/028157 patent/WO2001032853A1/en active Application Filing
- 2000-10-12 AU AU11970/01A patent/AU1197001A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001032853A1 (en) | 2001-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001292539A1 (en) | Fuel cell assembly and method for making the same | |
AU1290001A (en) | Antibodies | |
AU6864600A (en) | Fuel cell | |
AU2001213236A1 (en) | Mini-cyclone biocollector and concentrator | |
AU7989400A (en) | Compounds and methods | |
AU3215500A (en) | Compounds and methods | |
AU2736101A (en) | Transporters and ion channels | |
AU6136499A (en) | Injector, methods for using injector, and kit | |
AU2001249466A1 (en) | System and methods for designing group retirement plans | |
AU6955100A (en) | Battery | |
AU2003256710A1 (en) | Auto-stimulating cells and method for making and using the same | |
AU5043600A (en) | Battery | |
AU3360600A (en) | Content certification | |
AU1106401A (en) | Battery | |
AU6635800A (en) | Pyridomorphinans, thienomoprhinans and use thereof | |
AU5171600A (en) | Battery | |
AU2001293118A1 (en) | Dosimeter and method for using the same | |
AU7849200A (en) | Mannosidases and methods for using same | |
AU4625100A (en) | Stable catalysts and processes for making and using the same | |
AU7649400A (en) | Nippers | |
AU1083501A (en) | Antibiotic-metal complex and methods | |
AU4312101A (en) | Secure delivery receptacle and method for using the same | |
AU1197001A (en) | B cell clonal toxins and methods for using the same | |
EP1170811A3 (en) | Fuel cell system and method for operating the system | |
AU7641898A (en) | Ion paris, method for the production and use thereof as contrast agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |